Joshua's Future Of Promises

Call Directions Website Contact the organization

Joshua's Future Of Promises Joshua’s Future Of Promises is a non-profit organization in honor of Joshua Scoble and in search of a cure for Fibrodysplasia Ossificans Progressiva (FOP).

Joshua Scoble was born with a genetic disorder called FOP (Fibrodysplasia Ossificans Progressiva). FOP is a rare genetic disorder that affects about 700 people WORLD WIDE. When you have FOP, any kind of trauma, such as, injections, bumping or falling, this may result in a “flare-up”. Having a flare-up causes muscle to turn to bone, and in turn that bone will then attach to any existing bone and cause joints to lock or freeze up. Some refer to the FOP patients as “Human Statues”. Dr. Kaplan, the leading FOP doctor, has been tirelessly working on finding a cure with the hope that FOP patients can lead a better life.

10/10/2026

Joshua had an amazing time at Rutgers University yesterday, showcasing the exciting world of power wheelchair hockey! 🏒

Along with some of his Philadelphia PowerPlay teammates, Joshua participated in a live demo and mini hockey game alongside a Volt Hockey athlete and members of the audience —giving everyone a chance to experience the fun and excitement of adaptive sports firsthand!

Before his own demo, Joshua watched teams play adaptive soccer and another form of floor hockey.

The expo was hosted by Rutgers’ disability assistance staff and its partners to raise awareness about the importance of adaptive sports. It also served as an opportunity for Rutgers to explore opportunities to establish their own adaptive sports teams.

Events like these help highlight the power of inclusion, accessibility, and ensuring that everyone has the opportunity to experience the joy of sports!

Less than 1️⃣ week left of our Keystone Candle Fundraiser! 🕯️Tell your friends! Family! Coworkers! So many scents to enj...
09/24/2026

Less than 1️⃣ week left of our Keystone Candle Fundraiser! 🕯️

Tell your friends! Family! Coworkers!

So many scents to enjoy! & Just in time for the holidays! 🎃🎄🎁

⚠️ Order forms must be dropped off and/or have a postage date BY OCTOBER 1st! ⚠️

Just a reminder that our Keystone Candle Fundraiser is happening ALL MONTH LONG! Download our order form, share with you...
09/10/2026

Just a reminder that our Keystone Candle Fundraiser is happening ALL MONTH LONG!

Download our order form, share with your friends & family, and submit your form by October 1st!!!

Make your house smell great while also supporting a great cause! 😌

Our annual Keystone Candle fundraiser is back! 🕯️🍂It's officially candle season, and we're excited to kick off our annua...
09/01/2026

Our annual Keystone Candle fundraiser is back! 🕯️🍂

It's officially candle season, and we're excited to kick off our annual candle fundraiser with our wonderful friends at Keystone Candle Company!

Throughout the entire month of September, you can purchase beautifully handcrafted candles while supporting Joshua's Future Of Promises and our mission to fund research for FOP.

To order:
📝 Complete an order form (linked at the bottom for you to download & print).
💲 Make checks payable to "Joshua's FOP"
📍 Mail or drop off your payment and order form to Buss Paints in Emmaus BEFORE OCTOBER 1ST!

We are so grateful to Keystone Candle Company for partnering with us year after year, and to each of you for your continued generosity and support. Every order helps move our mission forward, and we couldn't do it without this amazing community.

Thank you for helping us light the way toward a cure. 💚🕯️💙

Questions? Send us a message or call 610-349-8479 📞

https://drive.google.com/file/d/1Z7kUx0losQbllc0f3VVoO2rGQtEYFtRM/view?usp=sharing

The IFOPA is pleased to share breaking news-approval of Regeneron's drug in the US! Thanks to all who took part in the t...
08/20/2026

The IFOPA is pleased to share breaking news-approval of Regeneron's drug in the US! Thanks to all who took part in the trial! 💙💚

💡 Do you know what Pasatru™ is?
It is the brand name for Regeneron's drug garetosmab, which has been approved today in the 🇺🇸 United States to treat FOP.

Pasatru™ (garetosmab) is only the second drug approved for FOP in the U.S., and the first shown to have an impact on both bone growth and flare-ups.

As we announce this decision, we are deeply grateful to people living with FOP from around the world who participated in two pivotal trials of garetsomab: LUMINA-1 Phase 2 and OPTIMA Phase 3 🙌

We also want to thank Regeneron and its employees for their long-standing commitment and dedication to the FOP community. This drug was invented by scientists at Regeneron who were looking for ways to treat FOP by blocking heterotopic bone growth 👏

📌 Learn more and read Regeneron’s press release: ifopa.org/garetosmab-fda-approval

Congratulations to the FOP community on this very special day! 💚💙

What an AWESOME night at the Luke Bryan concert! 🎶🎤🎸Josh had lots of fun and even ran into (& got a picture with) one of...
06/27/2026

What an AWESOME night at the Luke Bryan concert! 🎶🎤🎸

Josh had lots of fun and even ran into (& got a picture with) one of the openers, Shane Profitt. 🤠

First of many concerts this year for Joshua! 🎶🎤🎸Luke Bryan @ PPL Center in Allentown 🤠
06/25/2026

First of many concerts this year for Joshua! 🎶🎤🎸

Luke Bryan @ PPL Center in Allentown 🤠

Buy Pizza, Raise Dough! 🍕💸Don't forget to use our code when you purchase Papa John's pizza! Use "JFOP" to receive a disc...
06/03/2026

Buy Pizza, Raise Dough! 🍕💸

Don't forget to use our code when you purchase Papa John's pizza!

Use "JFOP" to receive a discount AND support our cause! Fundraising never tasted so delicious! 😋

*Only at select locations*

This is exciting news for the FOP community! 💙💚Mirum Pharmaceuticals announced that it has acquired the rights to zilurg...
05/12/2026

This is exciting news for the FOP community! 💙💚

Mirum Pharmaceuticals announced that it has acquired the rights to zilurgisertib, a drug currently being studied as a possible treatment for FOP in the PROGRESS Phase 2 trial.

Even more encouraging, results from Part 1 of the trial (patients ages 12+) have been submitted to the FDA and granted Priority Review (meaning the review process will move faster than normal). The FDA is expected to make a decision by September 26, 2026.

The Scoble family is beyond grateful for your support for the past 19 years. A large portion of the funds donated to Joshua’s Future Of Promises have helped us reach this research milestone. Your donations are making a difference. Thank you to everyone who has supported our cause. 💙💚

For more information, visit ifopa.org.

We’re expanding our commitment to the rare disease community.

Mirum has in-licensed exclusive worldwide rights to zilurgisertib, an investigational oral therapy in development for fibrodysplasia ossificans progressiva (FOP)—an ultra-rare genetic disease, from Incyte.

The FDA has accepted the NDA for zilurgisertib and granted Priority Review, with a PDUFA date of September 26, 2026.

This moment reflects years of progress driven by the FOP community, and we’re honored to add our voice to that foundation.

For patients living with FOP and their families, new treatment options cannot come soon enough. We’re committed to working with urgency to bring this potential therapy forward.

Address

327 Main Street
Emmaus, PA
18049

Alerts

Be the first to know and let us send you an email when Joshua's Future Of Promises posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Joshua's Future Of Promises:

Share